Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Aroon Oscillator

Score

0.35

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 7 38.4 0.43% 0.75% 13.3% -6.5% 13.8%
SHORT 6 76.5 0.50% 0.75% 6.3% -3.9% 3.4%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

AROON OSCILLATOR


Last Signal:

NEUTRAL


Trading: HOLD @ $0.8
Signal Strength: STRONG
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has been constructed to highlight the existence of a trend for an assocaited timeframe. Trend determining indicators can be used in short, medium or long term timeframes & determines if the stock is trending or ranging. Once the trend status is quantified, this can then be coupled to additional indicators to add a significant advantage to the trading strategy.


Opthea (ASX:OPT)


The Aroon Oscillator is the difference between Aroon-Up and Aroon-Down. These two indicators are usually plotted together for easy comparison but chartists can also view the difference of these two indicators with the Aroon Oscillator. This indicator fluctuates between -100 and +100 with zero as the middle line.

Calculation: Aroon Oscillator (ARO) :
1) Aroon Up = 100 x (25 - Days Since 25-day High)/25;
2) Aroon Down = 100 x (25 - Days Since 25-day Low)/25;
3) Aroon Oscillator = Aroon-Up - Aroon-Down;


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Aroon Oscillator

Download
Company Close Change(%) Volume Value Signal
MOY Millennium Minerals 0.13 13.6 1,861,319 16 BULLISH
ONE Oneview Healthcare 0.29 11.8 184,305 64 BULLISH
SLR Silver Lake Resources 1.45 8.2 9,252,383 96 BULLISH
MXI Maxitra Industries 0.33 8.2 24,282 24 BULLISH
RSG Resolute Mining 1.74 7.1 9,161,059 68 BULLISH
PRU Perseus Mining 0.71 6.8 12,414,565 68 BULLISH
AEF Australian Ethical Investments 2.03 6.8 76,257 52 BULLISH
AQG Alacer Gold Corp 5.42 6.3 936,317 96 BULLISH
NST Northern Star Resources 13.47 6 4,840,454 92 BULLISH
WAF West African Resources 0.39 5.4 3,897,020 80 BULLISH